The company officially joined Discovery Park in July 2024 using the science park’s small molecule API pilot plant and laboratory space to meet global demand for its pharmaceutical services.
Its plans include extending the site’s manufacturing capabilities.
Asymchem is a Chinese owned bio-pharma service provider that employs more than 9,300 people around the world. More than 100 people will be employed at the new facility in Sandwich.